Current Trials

Allergan BEACON (Geographic Atrophy):

A Phase 2, Randomized, Double-Masked Study of the Safety and Efficacy of Brimonidine Posterior Segment Drug Delivery System in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration

Alcon HAWK (Neovascular Age-Related Macular Degeneration):

A Phase 3, Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration

Genentech LADDER (Subfoveal Neovascular Age-Related Macular Degeneration):

A Phase 2, Multicenter, Randomized, Active Treatment-Controlled Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

Allergan SAPLING (Neovascular Age-Related Macular Degeneration):

A Phase 1 Study for the Evaluation of Safety and Systemic Pharmacokinetics after Single and Repeat Doses of Abicipar Pegol (AGN-150998) Intravitreal Injections in Patients with Neovascular Age-Related Macular Degeneration

Regeneron PANORAMA (Nonproliferative Diabetic Retinopathy):

A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients with Moderately Severe to Severe Nonproliferative Diabetic Retinopathy

Clearside Biomedical SAPPHIRE (Branch or Central Retinal Vein Occlusion):

A Phase 2, Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA in Conjunction with Intravitreal Aflibercept in Subjects with Branch or Central Retinal Vein Occlusion

Retina Patient Outcomes Registry with Retrospective and Prospective Chart Review:

A Study where charts of subjects under our care in the Retina Service would be reviewed so that we may be able to improve the quality of their care in our clinics at UCSD.